The Gross Margin of Neuren Pharmaceuticals Ltd (NEU.AX) is 18.56%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-12-31 | 18.56% |
2023-12-31 | 12.65% |